← Back to Search

Behavioural Intervention

Virtual Reality Mindfulness Treatment for Opioid Use Disorder

N/A

Recruiting

Led By Risa Weisberg, PhD

Research Sponsored by BehaVR LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

prescribed medications for opioid use disorder (e.g., buprenorphine, methadone)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3 months post treatment (20 weeks from baseline)

Awards & highlights

Study Summary

This trial tests if adding virtual reality-based mindfulness treatment to usual opioid use disorder treatment helps reduce opioid use.

Who is the study for?

This trial is for adults over 18 with opioid use disorder who are currently on medication like buprenorphine or methadone. It's not for those who've done mindfulness training, have active psychosis or suicidality, cognitive impairments, or conditions that make using VR risky (like seizures).Check my eligibility

What is being tested?

The study tests if a virtual reality program called MORE-VR can help people with opioid addiction better than usual treatments alone. Participants will either get their regular treatment plus weekly MORE-VR sessions for two months or just continue their normal care.See study design

What are the potential side effects?

Potential side effects from the VR intervention could include discomforts such as dizziness, nausea related to motion sickness, eye strain, and in rare cases seizures due to flashing lights.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am taking medication for opioid addiction.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3 months post treatment (20 weeks from baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3 months post treatment (20 weeks from baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months post treatment (20 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Days of opioid use

Secondary outcome measures

Days of opioid use at follow-up

Desire for drugs

Distress

+7 more

Other outcome measures

Drug cue reactivity

Emotion regulation

Theta oscillations

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MORE-VRExperimental Treatment2 Interventions

An 8-session version of Mindfulness-Oriented Recovery Enhancement (MORE) delivered by virtual reality. The treatment involves training in mindfulness, reappraisal, and savoring techniques to address OUD. Participants in this arm will also receive Treatment as usual (TAU) with medications for opioid use disorder (MOUD) such as buprenorphine, methadone, or naltrexone plus any psychological counseling they are already receiving in their standard care.

Group II: Treatment as Usual (TAU)Active Control1 Intervention

Treatment as usual (TAU) with medications for opioid use disorder (MOUD) such as buprenorphine, methadone, or naltrexone plus any psychological counseling they are already receiving in their standard care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MORE-VR

2021

N/A

~40

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

BehaVR LLCLead Sponsor

2 Previous Clinical Trials

90 Total Patients Enrolled

University of UtahOTHER

1,100 Previous Clinical Trials

1,778,573 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,603 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively recruiting participants?

"According to the information on clinicaltrials.gov, this trial has since ceased recruitment efforts; however, there are still 531 studies that need volunteers at present. This experimental project was initially posted in September 1st 2023 and its latest update occured two days later."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT

2023. "Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06021431.